TESTICULAR CANCER METASTATIC

This adverse event was reported 86 times

These drugs are most commonly taken by patients reporting TESTICULAR CANCER METASTATIC:

# Drug Count
0 CISPLATIN 12
1 BLEOMYCIN SULFATE 9
2 CLOZAPINE 8
3 ETOPOSIDE 8
4 ADALIMUMAB 7
5 AZATHIOPRINE 7
6 ALLOPURINOL 6
7 METHYLPREDNISOLONE 6
8 SPIRONOLACTONE 6
9 BLEOMYCIN 5
See all common drugs associated with TESTICULAR CANCER METASTATIC

TESTICULAR CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 STREPTOMYCIN 1 0.0009
1 BLEOMYCIN SULFATE 9 0.0009
2 SOTALOL HYDROCHLORIDE TABLES AF 1 0.0004
3 SOTALOL HYDROCHLORIDE TABLETS AF 1 0.0004
4 COAGULATION FACTOR VIIA (RECOMBINANT) 1 0.0004
5 CAPIVASERTIB 1 0.0003
6 CEFAZOLIN SODIUM 2 0.0002
7 CISPLATIN 12 0.0002
8 DICLOFENAC SODIUM AND MISOPROSTOL 1 0.0002
9 MERCAPTOPURINE 2 0.0001
See all drugs enriched for association with TESTICULAR CANCER METASTATIC

TESTICULAR CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 8 0.0001
1 Asparagine-specific Enzyme [EPC] 1 0.0001
2 Purine Antimetabolite [EPC] 7 0.0001
3 Stimulant Laxative [EPC] 1 0.0001
4 Prostaglandin E1 Analog [EPC] 1 0.0001
5 Platinum-based Drug [EPC] 14 0.0001
6 Aluminum Complex [EPC] 1 0.0000
7 Antimycobacterial [EPC] 1 0.0000
8 Aldosterone Antagonist [EPC] 6 0.0000
9 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
See all drug classes enriched for association with TESTICULAR CANCER METASTATIC